Micropapillary Urothelial Carcinoma of the Bladder: A Systematic Review and Meta-analysis of Disease Characteristics and Treatment Outcomes

Amin, 1994, Micropapillary variant of transitional cell carcinoma of the urinary bladder Histologic pattern resembling ovarian papillary serous carcinoma, Am J Surg Pathol, 18, 1224, 10.1097/00000478-199412000-00005 Spaliviero, 2014, Clinical outcome of patients with T1 micropapillary urothelial carcinoma of the bladder, J Urol, 192, 702, 10.1016/j.juro.2014.02.2565 Moschini, 2017, Incidence and effect of variant histology on oncological outcomes in patients with bladder cancer treated with radical cystectomy, Urol Oncol Semin Orig Investig, 35, 335, 10.1016/j.urolonc.2016.12.006 Amin, 2012, Noninvasive micropapillary urothelial carcinoma: a clinicopathologic study of 18 cases, Hum Pathol, 43, 2124, 10.1016/j.humpath.2012.04.013 Moschini, 2017, Characteristics and clinical significance of histological variants of bladder cancer, Nat Rev Urol, 14, 651, 10.1038/nrurol.2017.125 Guo, 2016, Gene expression profile of the clinically aggressive micropapillary variant of bladder cancer, Eur Urol, 70, 611, 10.1016/j.eururo.2016.02.056 Choi, 2014, Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy, Cancer Cell, 25, 152, 10.1016/j.ccr.2014.01.009 Willis, 2014, Micropapillary bladder cancer: current treatment patterns and review of the literature, Urol Oncol, 32, 826, 10.1016/j.urolonc.2014.01.020 Kamat, 2007, Micropapillary bladder cancer, Cancer, 110, 62, 10.1002/cncr.22756 Willis, 2015, Clinical outcomes of cT1 micropapillary bladder cancer, J Urol, 193, 1129, 10.1016/j.juro.2014.09.092 Sui, 2016, Micropapillary bladder cancer: insights from the National Cancer Database, Bladder Cancer, 2, 415, 10.3233/BLC-160066 Holyoak, 2013, Micropapillary bladder cancer: stage at presentation and treatment outcome—analysis of 121 patients from a cancer database, J Clin Oncol, 31, 289, 10.1200/jco.2013.31.6_suppl.289 American Urological Association. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO joint guideline. American Urological Association Web site. http://www.auanet.org/guidelines/non-muscle-invasive-bladder-cancer-(aua/suo-joint-guideline-2016). Boorjian, 2017, NCCN guidelines index Ghoneim, 2011, Neoadjuvant systemic therapy or early cystectomy? Single-center analysis of outcomes after therapy for patients with clinically localized micropapillary urothelial carcinoma of the bladder, Urology, 77, 867, 10.1016/j.urology.2010.11.043 Fernández, 2017, Clinical risk stratification in patients with surgically resectable micropapillary bladder cancer, BJU Int, 119, 684, 10.1111/bju.13689 Meeks, 2013, Pathological response to neoadjuvant chemotherapy for muscle-invasive micropapillary bladder cancer, BJU Int, 111, E325, 10.1111/j.1464-410X.2012.11751.x Liberati, 2009, The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration, BMJ, 339, 2700, 10.1136/bmj.b2700 2011 Higgins, 2011, The Cochrane Collaboration's tool for assessing risk of bias in randomised trials, BMJ, 343, 5928, 10.1136/bmj.d5928 Compérat, 2010, Micropapillary urothelial carcinoma of the urinary bladder: a clinicopathological analysis of 72 cases, Pathology, 42, 650, 10.3109/00313025.2010.522173 Ben Khalifa, 2017, Impact of micropapillary carcinoma variant proportion on prognosis in urothelial carcinoma of the bladder, Virchows Arch, 471, S273 Jackson, 2015, Is immediate radical cystectomy necessary for all patients with non-muscle-invasive micropapillary bladder cancer?, Urol Int, 96, 32, 10.1159/000375411 Tripathi, 2017, Impact of variant histology on disease-specific mortality and survival in patients with non-muscle invasive bladder cancer (NMIBC): a population-based analysis, J Clin Oncol, 35, 332, 10.1200/JCO.2017.35.6_suppl.332 Mendiratta, 2018, Clinicopathologic factors, treatment patterns, and outcomes in micropapillary urothelial carcinoma (UC), J Clin Oncol, 36, 439, 10.1200/JCO.2018.36.6_suppl.439 Vetterlein, 2017, Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology, Cancer, 123, 4346, 10.1002/cncr.30907 Joshi, 2017, Systemic therapy and overall survival trends in patients with non-urothelial histologic variants of muscle invasive bladder cancer undergoing radical cystectomy, J Clin Oncol, 35, 376, 10.1200/JCO.2017.35.6_suppl.376 Gelpi-Hammerschmidt, 2016, MP01-18 the potential impact of neoadjuvant chemotherapy on patients undergoing radical cystectomy for non-urothelial muscle invasive bladder cancer, J Urol, 195, e8, 10.1016/j.juro.2016.02.1848 Canvasser, 2014, MP50-06 micropapillary differentiation versus conventional urothelial carcinoma: effects of neoadjuvant chemotherapy and cystectomy on survival, J Urol, 191, e495, 10.1016/j.juro.2014.02.1127 Fairey, 2014, Impact of micropapillary urothelial carcinoma variant histology on survival after radical cystectomy, Urol Oncol Semin Orig Investig, 32, 110, 10.1016/j.urolonc.2012.04.020 Monn, 2015, Contemporary bladder cancer: variant histology may be a significant driver of disease, Urol Oncol, 33, 10.1016/j.urolonc.2014.10.001 Masson-Lecomte, 2014, Impact of micropapillary histological variant on survival after radical nephroureterectomy for upper tract urothelial carcinoma, World J Urol, 32, 531, 10.1007/s00345-013-1141-0 Gaya, 2010, The case for conservative management in the treatment of patients with non-muscle-invasive micropapillary bladder carcinoma without carcinoma in situ, Can J Urol, 17, 5370 Keck, 2013, Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy, BMC Cancer, 13, 71, 10.1186/1471-2407-13-71 Babjuk, 2017, EAU guidelines on non–muscle-invasive urothelial carcinoma of the bladder: update 2016, Eur Urol, 71, 447, 10.1016/j.eururo.2016.05.041 McQuitty, 2012, Lymphovascular invasion in micropapillary urothelial carcinoma: a study of 22 cases, Arch Pathol Lab Med, 136, 635, 10.5858/arpa.2011-0463-OA Kamat, 2006, The case for early cystectomy in the treatment of nonmuscle invasive micropapillary bladder carcinoma, J Urol, 175, 881, 10.1016/S0022-5347(05)00423-4 Siefker-Radtke, 2013, A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer, Cancer, 119, 540, 10.1002/cncr.27751 Stein, 2001, Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients, J Clin Oncol, 19, 666, 10.1200/JCO.2001.19.3.666 Wang, 2012, Outcomes following radical cystectomy for micropapillary bladder cancer versus pure urothelial carcinoma: a matched cohort analysis, World J Urol [Internet], 30, 801, 10.1007/s00345-012-0976-0 Cai, 2014, Concordance and clinical significance of uncommon variants of bladder urothelial carcinoma in transurethral resection and radical cystectomy specimens, Urology [Internet], 84, 1141, 10.1016/j.urology.2014.06.032